INTRODUCTION: Carbon monoxide (CO) released from CORM-2 has anti-inflammatory function, but the critical molecule mediating the inflammation inhibition has not been elucidated. Previous studies indicate that CORM-2 can activate Nrf2, a key transcription factor regulating host defense against oxidative stress and inflammation-related disorders. In this study we use Nrf2 knockout mice to determine the role of Nrf2 in mediating the CO anti-inflammatory action. METHODS: We compared CORM-2's inhibiting effect on pro-inflammatory cytokine expressions (TNF-α, IL-1β and IL-6 and iNOS) in primary peritoneal macrophages, mouse liver and brain tissues from Nrf2(+/+) and Nrf2(-/-) mice. We further assayed the inflammatory cell infiltration in both liver and brain tissues of the Nrf2(+/+) and Nrf2(-/-) mice. Finally, we examined CORM's influence on mouse mortality in a mouse sepsis model. RESULTS: Our results showed that CORM-2 dramatically inhibited the expression of pro-inflammatory cytokines in Nrf2(+/+) mice, but not in Nrf2(-/-) mice. Furthermore CORM-2 substantially decreased LPS-induced mouse mortality of Nrf2(+/+) mice, but not of Nrf2(-/-) mice. CONCLUSION: We conclude that Nrf2 is indispensable for CORM-2 inhibition of LPS-induced inflammation.
INTRODUCTION:Carbon monoxide (CO) released from CORM-2 has anti-inflammatory function, but the critical molecule mediating the inflammation inhibition has not been elucidated. Previous studies indicate that CORM-2 can activate Nrf2, a key transcription factor regulating host defense against oxidative stress and inflammation-related disorders. In this study we use Nrf2 knockout mice to determine the role of Nrf2 in mediating the CO anti-inflammatory action. METHODS: We compared CORM-2's inhibiting effect on pro-inflammatory cytokine expressions (TNF-α, IL-1β and IL-6 and iNOS) in primary peritoneal macrophages, mouse liver and brain tissues from Nrf2(+/+) and Nrf2(-/-) mice. We further assayed the inflammatory cell infiltration in both liver and brain tissues of the Nrf2(+/+) and Nrf2(-/-) mice. Finally, we examined CORM's influence on mouse mortality in a mousesepsis model. RESULTS: Our results showed that CORM-2 dramatically inhibited the expression of pro-inflammatory cytokines in Nrf2(+/+) mice, but not in Nrf2(-/-) mice. Furthermore CORM-2 substantially decreased LPS-induced mouse mortality of Nrf2(+/+) mice, but not of Nrf2(-/-) mice. CONCLUSION: We conclude that Nrf2 is indispensable for CORM-2 inhibition of LPS-induced inflammation.
Authors: Mohamed G Bani-Hani; David Greenstein; Brian E Mann; Colin J Green; Roberto Motterlini Journal: J Pharmacol Exp Ther Date: 2006-06-13 Impact factor: 4.030
Authors: Michelle L Hernandez; Bradford Harris; John C Lay; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden Journal: Inhal Toxicol Date: 2010-07 Impact factor: 2.724
Authors: Florian B Mayr; Alexander Spiel; Judith Leitner; Claudia Marsik; Peter Germann; Roman Ullrich; Oswald Wagner; Bernd Jilma Journal: Am J Respir Crit Care Med Date: 2004-11-19 Impact factor: 21.405
Authors: Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal Journal: Antioxid Redox Signal Date: 2007-11 Impact factor: 8.401
Authors: Wei Jin; Lin Zhu; Qun Guan; Gang Chen; Qing Feng Wang; Hong Xia Yin; Chun Hua Hang; Ji Xin Shi; Han Dong Wang Journal: Ann Clin Lab Sci Date: 2008 Impact factor: 1.256
Authors: Refaat A F Hegazi; Kavitha N Rao; Aqila Mayle; Antonia R Sepulveda; Leo E Otterbein; Scott E Plevy Journal: J Exp Med Date: 2005-12-19 Impact factor: 14.307
Authors: Dana C Borcherding; Matthew E Siefert; Songbai Lin; John Brewington; Hesham Sadek; John P Clancy; Scott M Plafker; Assem G Ziady Journal: J Clin Invest Date: 2019-05-30 Impact factor: 14.808
Authors: Katarzyna Magierowska; Marcin Magierowski; Magdalena Hubalewska-Mazgaj; Juliusz Adamski; Marcin Surmiak; Zbigniew Sliwowski; Slawomir Kwiecien; Tomasz Brzozowski Journal: PLoS One Date: 2015-10-13 Impact factor: 3.240
Authors: András Tamás Mészáros; Ágnes Lilla Szilágyi; László Juhász; Eszter Tuboly; Dániel Érces; Gabriella Varga; Petra Hartmann Journal: Front Med (Lausanne) Date: 2017-11-13